WANY
MBOT icon

Wealthspire Advisors (New York)’s Microbot Medical MBOT Stock Holding History

Wealthspire Advisors (New York)’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$3 – 2127
2025
Q3 		$3 Buy
+1
New +$3 ﹤0.01% 3054

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthspire Advisors (New York)'s MBOT Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Microbot Medical (MBOT) in Q4 2025, closing a stake of 1 share — an estimated $3 sold.

Wealthspire Advisors (New York) first reported a position in MBOT in Q3 2025 and held it in 1 quarter. The position peaked at $3 in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Microbot Medical position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1 Microbot Medical share in Q4 2025, an estimated $3.
  • Wealthspire Advisors (New York) first reported a position in Microbot Medical in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Microbot Medical position peaked at $3 in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.